Claim: The AFIB Technology has been tested by clinical studies and the blood pressure monitor which uses AFIB Technology had a sensitivity of 100% from Microlife, founded in 1981 whose headquarters are in Taiwan.
Evidence: Several clinical studies have tested the Microlife AFIB Technology against 12-lead electrocardiography (ECG) interpreted by cardiologists. One study indicated that the Microlife blood pressure monitor had a sensitivity for detecting atrial fibrillation of 100%, a specificity of 92%. Taipei, Taiwan 1981 (1981) Taipei, Taiwan